Therapeutic Asset Ratings
396 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
CIS-DIAMMINEDICHLOROPLATINUM II
Chondrosarcoma
Eli Lilly and Company
P1/2
CCC
(55)
DEXAMETHASONE
Alzheimer Disease
Eli Lilly and Company
P3
CCC
(54)
EXEMESTANE
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Imlunestrant
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
ly4064809
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Mirvetuximab Soravtansine
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Mirvetuximab Soravtansine
Ovarian Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Olomorasib
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Ribociclib
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Sofetabart Mipitecan
Metastatic Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Sofetabart Mipitecan
Ovarian Neoplasm
Eli Lilly and Company
P3
CCC
(54)
Cyclophosphamide
Ureteral Neoplasms
Eli Lilly and Company
P1/2
CCC
(54)
Epirubicin
Ureteral Neoplasms
Eli Lilly and Company
P1/2
CCC
(54)
Pembrolizumab
Ureter Neoplasm
Eli Lilly and Company
P1/2
CCC
(54)
Donanemab
Amyloidosis
Eli Lilly and Company
P2
CCC
(53)
Donanemab
Lewy Body Dementia
Eli Lilly and Company
P2
CCC
(53)
Donanemab
Synucleinopathy
Eli Lilly and Company
P2
CCC
(53)
Eloralintide
Type 2 Diabetes Mellitus
Eli Lilly and Company
P2
CCC
(53)
Fepixnebart
Osteoarthritis, Knee
Eli Lilly and Company
P2
CCC
(53)
ly3549492
Obesity Disorder
Eli Lilly and Company
P2
CCC
(53)
ly3556050
Osteoarthritis, Knee
Eli Lilly and Company
P2
CCC
(53)
ly3857210
Osteoarthritis, Knee
Eli Lilly and Company
P2
CCC
(53)
ly4065967
Diabetic Neuropathy
Eli Lilly and Company
P2
CCC
(53)
ly4065967
Low Back Pain
Eli Lilly and Company
P2
CCC
(53)
ly4065967
Osteoarthritis, Knee
Eli Lilly and Company
P2
CCC
(53)
Showing 176 to 200 of 396 assets
Previous
Page 8 of 16
Next